Suchergebnisse - "Moroni, Flavio"

PubPharm (154)

1

Differential mechanisms of tolerance induced by NMDA and 3,5-dihydroxyphenylglycine (DHPG) preconditioning

enthalten in: Journal of neurochemistry | 2020

von Gerace, E. | Zianni, E. | Landucci, E. | +8

2

Differential mechanisms of tolerance induced by NMDA and 3,5‐dihydroxyphenylglycine (DHPG) preconditioning

enthalten in: Journal of Neurochemistry | 2020

von Gerace, E. | Zianni, E. | Landucci, E. | +8

3

Effects of PARP-1 Deficiency and Histamine H4 Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in Mice

enthalten in: Frontiers in pharmacology | 2019

von Durante, M. | Sgambellone, S. | Lanzi, C. | +5

4

Thiazolyl- and Oxazolyl-Isoquinolinones and Methods for Using Them

enthalten in: Europäisches Patentamt | 2018

von PELLICCIARI ROBERTO | MORONI FLAVIO | GILBERT ADAM

5

enthalten in: Oncology research | 2018

von Mini, E. | Landini, I. | Lucarini, L. | +7

ErratumFor: Oncol Res. 2017 Nov 2;25(9):1441-1451. - PMID 28429680

6

Glutamate Receptor-Mediated Neurotoxicity in a Model of Ethanol Dependence and Withdrawal in Rat Organotypic Hippocampal Slice Cultures

enthalten in: Frontiers in neuroscience | 2018

von Gerace, E. | Landucci, E. | Bani, D. | +3

7

Methadone Dose Adjustments, Plasma R-Methadone Levels and Therapeutic Outcome of Heroin Users : A Randomized Clinical Trial

enthalten in: European addiction research | 2018

von Mannaioni, G. | Lanzi, C. | Lotti, M. | +17

CommentIn: Eur Addict Res. 2018;24(2):88. - PMID 29902789

8

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases

enthalten in: British journal of pharmacology | 2018

von Berger, N. | Besson, V. | Boulares, A. | +19

9

Response to Letter to the Editor by Ernesto de Bernadis

enthalten in: European addiction research | 2018

von Moroni, F. | Mannaioni, G.

CommentOn: Eur Addict Res. 2018;24(2):88. - PMID 29902789

10

The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways

enthalten in: Oncology research | 2017

von Mini, E. | Landini, I. | Lucarini, L. | +7

ErratumIn: Oncol Res. 2018 Mar 5;26(2):333-334. - PMID 29514732

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]